Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
